XOMA Royalty (XOMA) Exchange Rate Effect (2011 - 2018)
XOMA Royalty's (XOMA) quarterly Exchange Rate Effect came in at $20000.0 in Q1 2018, up 160.61% year-on-year from $7674.4 in Q1 2017, and up 66.67% quarter-over-quarter from $12000.0 in Q4 2017.
XOMA Royalty (XOMA) Exchange Rate Effect (2011 - 2018) Analysis & Trends
XOMA Royalty has disclosed Exchange Rate Effect across 6 years of filings, most recently posting $20000.0 for Q1 2018.
- Exchange Rate Effect for Q1 2018 came in at $20000.0, up 160.61% year-over-year; the trailing twelve-month figure through Dec 2018 was $20000.0 (down 88.83% YoY), and the FY2018 annual result was $20000.0, down 88.83% from the prior year.
- Exchange Rate Effect came in at $20000.0 for Q1 2018 at XOMA Royalty, up from $12000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $194000.0 in Q3 2017 to a low of -$152000.0 in Q3 2014.
- The 5-year median for Exchange Rate Effect is -$4000.0 (2015), against an average of -$785.71.
- Peak annual rise in Exchange Rate Effect reached 400.0% in 2017, while the deepest fall reached 1750.0% in 2017.
- XOMA Royalty's Exchange Rate Effect stood at -$15000.0 in 2014, then slumped by 60.0% to -$24000.0 in 2015, then soared by 83.33% to -$4000.0 in 2016, then jumped by 400.0% to $12000.0 in 2017, then jumped by 66.67% to $20000.0 in 2018.
- The last three Exchange Rate Effect figures came in at $20000.0 (Q1 2018), $12000.0 (Q4 2017), and $194000.0 (Q3 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 8.68 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 20,000.00 |
| Mar 31, 2018 | 20,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Sep 30, 2017 | 194,000.00 |
| Sep 30, 2017 | 194,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | -33,000.00 |
| Mar 31, 2017 | -33,000.00 |
| Dec 31, 2016 | -4,000.00 |
| Dec 31, 2016 | -4,000.00 |
| Jun 30, 2016 | -4,000.00 |
| Jun 30, 2016 | -4,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Dec 31, 2015 | -24,000.00 |
| Dec 31, 2015 | -24,000.00 |
| Sep 30, 2015 | 14,000.00 |
| Sep 30, 2015 | 14,000.00 |